Antigens, CD11c
-
Subject Areas on Research
- A CD91-positive subset of CD11c+ blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens.
- A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury.
- Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
- Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.
- CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion.
- Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
- Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
- Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.
- Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.
- Identification of new susceptibility loci for IgA nephropathy in Han Chinese.
- In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.
- Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.
- Protease-activated receptor-2 signaling triggers dendritic cell development.
- Socioeconomic status moderates associations between CNS serotonin and expression of beta2-integrins CD11b and CD11c.
- The role of dendritic cell precursors in tumour vasculogenesis.
-
Keywords of People
- Gunn, Michael Dee, Professor of Medicine, Integrative Immunobiology